1 Next, we investigated a human cohort to characterize the immu
2 Next, we investigated a model for spinocerebellar ataxia type
3 Next, we investigated a suspected category of nitromethane pr
4 Next, we investigated foam cell formation by CRP-bound E-LDL.
5 Next, we investigated genome-wide sharing of common variants
6 Next, we investigated how active vision impacts the emergence
7 Next, we investigated if expression of two neural plasticity
8 Next, we investigated if HCMV alters the activity in the thre
9 Next, we investigated in vivo expression of VEGF receptor-2 a
10 Next, we investigated NF-L efflux from the brain after SAH.
11 Next, we investigated receptor signalling via angiotensin typ
12 Next, we investigated relationships between the oral and gut
13 Next, we investigated Round Gobies collected from stream habi
14 Next, we investigated serums from vaccinated subjects and COV
15 Next, we investigated the clinical utility of this model to d
16 Next, we investigated the consequence of long-term nicotine e
17 Next, we investigated the cytotoxicity of the MCL lines upon
18 Next, we investigated the effects of cariporide on mitochondr
19 Next, we investigated the effects of IL-3 on in vitro expansi
20 Next, we investigated the evolutionary roots of unique bindin
21 Next, we investigated the general role of PI3K signaling in t
22 Next, we investigated the genetic architecture of this trait
23 Next, we investigated the impact of preventing hyperglycemia
24 Next, we investigated the initial stages of metastatic dissem
25 Next, we investigated the MS effects in the presence of a sma
26 Next, we investigated the oncogenic effect of EIF4A1 on cance
27 Next, we investigated the possible interaction between Gly121
28 Next, we investigated the rates of diversification among thes
29 Next, we investigated the relationship of ceramide to plasmin
30 Next, we investigated the role DJ-1 plays in modulating glyca
31 Next, we investigated the role of tyrosine phosphorylation pa
32 Next, we investigated the roles of individual cell types invo
33 Next, we investigated the therapeutic effectiveness of MBP-1
34 Next, we investigated the upstream mediator of Abeta-induced
35 Next, we investigated via immunolabeling procedures whether p
36 Next, we investigated whether altered haematopoiesis could ex
37 Next, we investigated whether behaviors linked to the hippoca
38 Next, we investigated whether CBR1 mRNA levels were altered i
39 Next, we investigated whether failure of corneal transplants
40 Next, we investigated whether mutant OA protein induces endop
41 Next, we investigated whether other members of the RASSF gene
42 Next, we investigated whether our bvFTD signature targets spe